pharmaceutical investing Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab
Red Metal Resources Reports First Ore Delivery from Farellon Ahead of Schedule, Launching Non-Dilutive Royalty Revenue
Spartan Metals Joins Defense Industrial Base Consortium as It Advances U.S. Tungsten and Critical Minerals Portfolio
